Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 12, Issue 5, Pages 1265-1273
Publisher
Informa UK Limited
Online
2016-02-20
DOI
10.1080/21645515.2015.1126012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994–2010
- (2015) Piraya Bhoomiboonchoo et al. BMC PUBLIC HEALTH
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation
- (2014) Marcin Kwissa et al. Cell Host & Microbe
- Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines
- (2014) R. Zust et al. JOURNAL OF VIROLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Mouse Models to Study Dengue Virus Immunology and Pathogenesis
- (2014) Raphaël M. Zellweger et al. Frontiers in Immunology
- Dengue Serotype Cross-Reactive, Anti-E Protein Antibodies Confound Specific Immune Memory for 1 Year after Infection
- (2014) Ying Xiu Toh et al. Frontiers in Immunology
- Current issues in dengue vaccination
- (2013) Stephen J. Thomas et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Memory B cells: a proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine
- (2013) Eiji Konishi Expert Review of Vaccines
- Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses
- (2013) Maja Jahnmatz et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced Risk of Disease During Postsecondary Dengue Virus Infections
- (2013) Sandra Olkowski et al. JOURNAL OF INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Plasmablasts Generated during Repeated Dengue Infection Are Virus Glycoprotein-Specific and Bind to Multiple Virus Serotypes
- (2012) M. Xu et al. JOURNAL OF IMMUNOLOGY
- Association between Magnitude of the Virus-Specific Plasmablast Response and Disease Severity in Dengue Patients
- (2012) T. M. Garcia-Bates et al. JOURNAL OF IMMUNOLOGY
- Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans
- (2012) J. Wrammert et al. JOURNAL OF VIROLOGY
- Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection
- (2012) L. Rivino et al. JOURNAL OF VIROLOGY
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years
- (2012) Yee Sin Leo et al. Human Vaccines & Immunotherapeutics
- Early Clinical Features of Dengue Virus Infection in Nicaraguan Children: A Longitudinal Analysis
- (2012) Hope H. Biswas et al. PLoS Neglected Tropical Diseases
- B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans
- (2011) Anuja Mathew et al. JOURNAL OF INFECTIOUS DISEASES
- Dengue Virus Activates Polyreactive, Natural IgG B Cells after Primary and Secondary Infection
- (2011) Thavamalar Balakrishnan et al. PLoS One
- Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue
- (2010) N. T. P. Dung et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started